Stock overview
Eli Lilly & Co.
Explore the company, reported ownership, price history, and available source evidence.
Eli Lilly develops medicines for diabetes, obesity, oncology, immunology, and neuroscience.
- Last close
- $1183.46
- · LLY
- Tracked holders
- 8 funds
- Latest available 13F per fund
LLY · USD
Price
$1183.46
+$957.06
(+422.73%)
over selected range
Close · Sep 25, 2026
Market closed
1255 stored daily closes
$1183.46
Sep 25, 2026
- Range low
- $221.60
- Range high
- $1,280.34
- Observations
- 1255
- Session date
- Sep 25, 2026
Sep 27, 2021–Sep 25, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| ARK Investment Management position history Q2 2026 · filed Aug 14, 2026 · SEC filing | +510% 26'Q2 | $92,660,897 | 0.6% |
| Gotham Asset Management position history Q2 2026 · filed Aug 14, 2026 · SEC filing | +36% 26'Q2 | $26,352,677 | 0.06% |
|
Thrive Capital
position history
Q2 2026
· filed Aug 14, 2026
· SEC filing 1 SEC filing 2 |
+11% 26'Q2 | $5,224,135 | 0.12% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market